Rennova Health, Inc.
RNVA
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 25.20% | 77.17% | 329.52% | 182.07% | 179.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.20% | 77.17% | 329.52% | 182.07% | 179.74% |
| Cost of Revenue | -0.93% | 16.70% | 34.80% | 64.01% | 50.99% |
| Gross Profit | 72.73% | 123.88% | 1,431.12% | 382.61% | 607.59% |
| SG&A Expenses | 25.75% | 25.45% | 40.98% | 228.62% | -10.37% |
| Depreciation & Amortization | -51.62% | -15.19% | -19.43% | -9.03% | -13.10% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.36% | 20.26% | 35.91% | 109.38% | 11.56% |
| Operating Income | 35.01% | 5,537.10% | 139.18% | 30,478.26% | 60.68% |
| Income Before Tax | 44.80% | 460.46% | 135.55% | 258.68% | -270.56% |
| Income Tax Expenses | -- | -- | -- | 74.26% | -- |
| Earnings from Continuing Operations | 58.58% | 357.02% | 135.55% | 192.32% | -270.56% |
| Earnings from Discontinued Operations | 35.29% | -107.69% | -- | -338.46% | -100.31% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.14% | 353.63% | 135.53% | 190.79% | -200.80% |
| EBIT | 35.01% | 5,537.10% | 139.18% | 30,478.26% | 60.68% |
| EBITDA | 32.60% | 1,322.54% | 146.95% | 1,111.27% | 63.57% |
| EPS Basic | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Normalized Basic EPS | 100.00% | 100.00% | 100.00% | -100.00% | 100.00% |
| EPS Diluted | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Normalized Diluted EPS | 100.00% | 100.00% | 100.00% | -100.00% | 100.00% |
| Average Basic Shares Outstanding | 197.09% | 1,658.62% | 618,144.64% | 1,283,474.90% | 24,076,374.49% |
| Average Diluted Shares Outstanding | 197.09% | 28,221.82% | 10,592,757.96% | 1,283,474.90% | 24,076,374.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |